 This is a single-center, randomized, open-label study to assess the feasibility of a low-protein diet intervention in patients with metastatic castrate-resistant prostate cancer CRPC who are receiving treatment with sipuleucel-T. Subjects will be randomized 1:1 ratio to either Arm 1 or Arm 2 Fig. 1. 